BTC $63,067.09 +0.52%
ETH $1,882.49 +0.40%
BNB $608.90 +0.44%
XRP $1.00 +1.02%
SOL $75.56 +0.68%
TRX $0.3310 -0.34%
DOGE $0.0698 +0.18%
ADA $0.1773 -0.71%
BCH $203.37 -0.05%
LINK $9.55 +6.82%
HYPE $57.05 +1.51%
AAVE $86.60 +1.51%
SUI $0.6798 +0.61%
XLM $0.1585 +1.25%
ZEC $488.86 -0.24%
BTC $63,067.09 +0.52%
ETH $1,882.49 +0.40%
BNB $608.90 +0.44%
XRP $1.00 +1.02%
SOL $75.56 +0.68%
TRX $0.3310 -0.34%
DOGE $0.0698 +0.18%
ADA $0.1773 -0.71%
BCH $203.37 -0.05%
LINK $9.55 +6.82%
HYPE $57.05 +1.51%
AAVE $86.60 +1.51%
SUI $0.6798 +0.61%
XLM $0.1585 +1.25%
ZEC $488.86 -0.24%

The publicly traded company Applied DNA Sciences disclosed that its initial BNB holdings are valued at over 17 million dollars

2025-10-22 20:20:58

ChainCatcher news, according to businesswire, biotechnology company Applied DNA Sciences, Inc. (NASDAQ: APDN) announced that it has completed the previously announced private equity investment (PIPE) financing led by institutional DeFi and TradFi investors, with an initial BNB holding valued at over $17 million.

The PIPE brought the company approximately $27 million in total proceeds, with the potential to gain an additional total of up to $31 million in the future through the exercise of warrants. The total proceeds from the PIPE transaction include $15.3 million in cash and stablecoins, as well as $11.71 million in OBNB trust units.

The company has received a total of 435,638 trust units, which represent underlying ownership of 10,647 BNB tokens. The company also announced today that it has additionally purchased 4,908 BNB tokens, estimated to be worth $5.3 million as of 10:00 PM Eastern Time on October 20, 2025.

app_icon
ChainCatcher Building the Web3 world with innovations.